PinkDx, Inc.
Marra Francis, MD, FACOG, is an experienced medical professional currently serving as Chief Medical Officer at PinkDx, Inc. since November 2024 and as a member of the Medical Advisory Board for Dama Health since July 2023. Marra also provides medical consultancy services for Droplet Biosciences, Inc. and runs Marra S. Francis Consulting, LLC, which focuses on clinical evaluation and positioning of emerging lab and biotechnologies. Previous roles include Chief Medical Officer at Genece Health, where efforts were directed towards cancer care improvements, and Head of Medical Affairs for Women’s Health at Sema4, highlighting advancements in precision medicine and genetics. Marra's educational background includes a Doctor of Medicine from The University of Connecticut Health Center and residency training in Obstetrics and Gynecology from New York University.
This person is not in any teams
PinkDx, Inc.
PinkDx is an early-stage women’s Healthcare company dedicated to building a leading enterprise bringing equitable care to women. Initially, the company is focused on the discovery and development of novel, new approaches to improve the journey millions of women navigate in getting answers to symptoms that are suspicious for cancer. PinkDx tests will improve patient outcomes, provide answers for physicians, and reduce the time and cost of care. The PinkDx co-founders are industry veterans with a passion for building a women’s health enterprise and for the opportunity to have impact for women all over the world. The Company has raised a $40 million Series A from top investors.